Global X MSCI Argentina ETF vs Baxter International Inc — how do they compare? Global X MSCI Argentina ETF trades at $92.05, while Baxter International Inc trades at $26.79 (market cap $14.27B). The key difference: Baxter International Inc pays a 0.14% dividend while Global X MSCI Argentina ETF pays none, and Baxter International Inc is trading nearer its 52-week high, Global X MSCI Argentina ETF nearer its low. Which is the better fit depends on your goals.
| ARGT | BAX | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $102.94 | $28.35 |
52-Week Low | $67.55 | $15.80 |
Market Cap | — | $14.27B |
Enterprise Value | — | $21.79B |
Dividend Yield | — | 0.14% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Baxter International Inc. (BAX) trades at $27.78, up 0.83% today, with a bullish technical outlook supported by moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.56 versus $0.37 expected, and revenue guidance was raised, signaling operational improvement. However, the company posted a net loss of -$957 million in 2025, with negative profit margins and high P/E of 87.85, reflecting valuation concerns amid turnaround efforts.
The stock shows potential from earnings momentum and cost initiatives, but high debt and inconsistent profitability pose risks. Analyst consensus is mixed with a $25.43 price target below current levels, suggesting cautious optimism. Investors should weigh recent beats against structural challenges in the medtech sector.
Trailing returns across standard periods
ARGT seeks to provide investment results that correspond to the performance of the MSCI All Argentina 25/50 Index. It offers targeted exposure to some of the largest and most liquid companies operating in Argentina.
Read more on ARGT →Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →